Last reviewed · How we verify

NCT06074224

Sleep Assessment: The Benefits of Identifying Sleep Disturbance Using a Sleep Questionnaire

Completed NA Last updated 31 July 2025
What this trial tests

NA trial testing Sleep assessment score in Sleep Disturbance in 114 participants. Completed in 1 December 2023.

Timeline
1 February 2022
Primary endpoint
1 September 2023
1 December 2023

Quick facts

Lead sponsorUniversity of Texas at Austin
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposebasic science
Enrollment114
Start date1 February 2022
Primary completion1 September 2023
Estimated completion1 December 2023
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Texas at Austin

Who can join

Adults 18 to 89, any sex, with Sleep Disturbance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators are interested in measuring the influence of addressing sleep in the orthopedic setting. This includes assessing patient experience measures (satisfaction with the visit, perceived empathy, communication effectiveness) as well as greater engagement in their healthcare (patient activation). The investigators will also see what factors might be associated with sleep disturbance and if addressing sleep leads to an intervention such as cognitive behavioral therapy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Sleep Disturbance

Currently open trials in the same condition.

Other University of Texas at Austin trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06074224.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing